CHASE SUN Trademark

Trademark Overview


On Monday, December 13, 2021, a trademark application was filed for CHASE SUN with the United States Patent and Trademark Office. The USPTO has given the CHASE SUN trademark a serial number of 97168784. The federal status of this trademark filing is REGISTERED as of Tuesday, August 8, 2023. This trademark is owned by Tianjin Chase Sun Pharmaceutical Co.,Ltd.. The CHASE SUN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceuticals, namely, anti-infectives
chase sun

General Information


Serial Number97168784
Word MarkCHASE SUN
Filing DateMonday, December 13, 2021
Status700 - REGISTERED
Status DateTuesday, August 8, 2023
Registration Number7134408
Registration DateTuesday, August 8, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "CHASE SUN". To the left of the wording is a shaded circle with a small circle and a wave curve inside. The small circle is positioned above the wave curve.
Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceuticals, namely, anti-infectives
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 16, 2021
Primary Code005
First Use Anywhere DateFriday, March 4, 2005
First Use In Commerce DateSaturday, June 1, 2013

Trademark Owner History


Party NameTianjin Chase Sun Pharmaceutical Co.,Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressTianjin N/A
CN

Party NameTianjin Chase Sun Pharmaceutical Co.,Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressTianjin N/A
CN

Party NameTianjin Chase Sun Pharmaceutical Co.,Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTianjin N/A
CN

Trademark Events


Event DateEvent Description
Tuesday, August 8, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 8, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, July 6, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, July 5, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 15, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 23, 2023USE AMENDMENT FILED
Thursday, June 15, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 23, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 20, 2022ASSIGNED TO EXAMINER
Friday, December 17, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 16, 2021NEW APPLICATION ENTERED